SecSonar.com

Palisade Bio, Inc. (PALI)

Palisade Bio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Palisade Bio, Inc. (PALI) is a Biotechnology company based in US with a market capitalization of $366.3M. Free cash flow was negative at -$10.8M. This page tracks PALI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 8 employees · IPO Mar 30, 2007

Valuation

Valuation & price

$1.83 · as of May 17, 2026 · -34.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.83

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.50$1.53$0.56Jul 25Dec 25Jul 26Jul 7, 25$0.73Jul 9, 25$0.76Jul 11, 25$0.75Jul 15, 25$0.75Jul 17, 25$0.75Jul 21, 25$0.95Jul 23, 25$1.22Jul 25, 25$1.16Jul 29, 25$1.09Jul 31, 25$1.02Aug 4, 25$1.04Aug 6, 25$1.00Aug 11, 25$0.74Aug 13, 25$0.81Aug 15, 25$0.80Aug 19, 25$0.78Aug 21, 25$0.73Aug 25, 25$0.69Aug 27, 25$0.66Aug 29, 25$0.68Sep 3, 25$0.65Sep 5, 25$0.63Sep 9, 25$0.56Sep 11, 25$0.58Sep 16, 25$0.60Sep 18, 25$0.60Sep 22, 25$0.63Sep 24, 25$0.68Sep 26, 25$0.90Sep 30, 25$0.86Oct 2, 25$1.70Oct 6, 25$1.91Oct 8, 25$2.00Oct 10, 25$2.00Oct 14, 25$1.85Oct 16, 25$1.73Oct 21, 25$1.77Oct 23, 25$1.77Oct 27, 25$1.66Oct 29, 25$2.12Oct 31, 25$2.07Nov 4, 25$1.84Nov 6, 25$1.66Nov 10, 25$1.77Nov 12, 25$2.04Nov 14, 25$2.14Nov 18, 25$2.07Nov 20, 25$2.34Nov 25, 25$2.15Nov 28, 25$2.11Dec 2, 25$1.83Dec 4, 25$1.80Dec 8, 25$1.81Dec 10, 25$2.10Dec 12, 25$1.94Dec 16, 25$1.72Dec 18, 25$1.67Dec 22, 25$2.08Dec 24, 25$2.20Dec 29, 25$2.48Jan 2, 26$2.50Jan 6, 26$1.92Jan 8, 26$1.90Jan 12, 26$1.90Jan 14, 26$1.95Jan 16, 26$1.66Jan 21, 26$1.75Jan 23, 26$1.91Jan 27, 26$1.81Jan 29, 26$1.61Feb 2, 26$1.61Feb 4, 26$1.58Feb 9, 26$1.72Feb 11, 26$1.74Feb 13, 26$1.73Feb 18, 26$1.69Feb 20, 26$1.60Feb 24, 26$1.79Feb 26, 26$1.85Mar 2, 26$1.81Mar 4, 26$1.74Mar 6, 26$1.63Mar 10, 26$1.92Mar 12, 26$2.03Mar 17, 26$1.99Mar 19, 26$1.99Mar 23, 26$1.91Mar 25, 26$2.00Mar 27, 26$2.00Mar 31, 26$1.75Apr 2, 26$1.89Apr 7, 26$1.91Apr 9, 26$1.98Apr 13, 26$1.99Apr 15, 26$2.34Apr 17, 26$2.40Apr 22, 26$2.34Apr 24, 26$2.08Apr 28, 26$1.95Apr 30, 26$2.00May 4, 26$2.13May 6, 26$2.00May 8, 26$1.80May 12, 26$1.92May 14, 26$1.81May 18, 26$1.81May 20, 26$1.88May 22, 26$1.95May 28, 26$2.06Jun 1, 26$2.08Jun 3, 26$1.93Jun 5, 26$1.74Jun 9, 26$1.69Jun 11, 26$1.78Jun 15, 26$1.69Jun 17, 26$1.76Jun 22, 26$1.84Jun 24, 26$1.92Jun 26, 26$1.89Jul 2, 26$2.10
$0.5452-week range$2.80
Loading valuation history…

Fundamentals

Key fundamentals

$366.3M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$10.8M

Free cash flow (USD)

-$133.3M

Net debt

Net cash position

3831.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$16.2KFY 2017$260.0KFY 2018$260.0KFY 2019$15.4KFY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$250.0KFY 2024$0.00FY 2025$0.00
$16.2K$0

Free cash flow by year

2016 → 2025

FY 2016$-15.8MFY 2017$-13.5MFY 2018$-7.7MFY 2019$-7.3MFY 2020$-4.8MFY 2021$-14.8MFY 2022$-13.4MFY 2023$-11.1MFY 2024$-12.2MFY 2025$-10.8M
-$15.8M-$10.8M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan AmendedJun 11, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • FinancingSecurities RegistrationMay 12, 2026Filing
  • 8-K eventStock IssuanceApr 2, 2026Filing

Questions

Frequently asked questions

What is Palisade Bio, Inc.'s market cap?

Palisade Bio, Inc. (PALI) has a market capitalization of $366.3M.

What is PALI's P/E ratio?

A meaningful P/E ratio is not available for PALI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PALI's price-to-book (P/B) ratio?

PALI trades at 2.83 times book value per share.

Are insiders buying PALI stock?

SEC Form 4 filings show no open-market insider buys at Palisade Bio, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

RGNX

REGENXBIO Inc.

$365.2M

CCCC

C4 Therapeutics, Inc.

$367.8M

PBYI

Puma Biotechnology, Inc.

$364.7M

IRD

Opus Genetics, Inc.

$364.7M

PTN

Palatin Technologies, Inc.

$368M

KROS

Keros Therapeutics, Inc.

$361.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.